The Cost-Saving Proposal That Costs Seniors $2,000 a Month
A Trump administration proposal designed to cut prescription drug costs could actually see some seniors paying $2,000 more each month out of their own pockets, a new study published in the Journal of the American Medical Association suggests.
New “Fast Facts” Highlights Impact of High Cholesterol on Europe
More than 50 percent of Europeans have raised cholesterol, increasing their risk of heart attack, stroke and death – and costing the EU billions every year in health care expenses and lost productivity. So explains a new “Fast Facts” policy brief from the European Alliance for Patient Access, a division of the Global Alliance for Patient Access.
Hello, Lower Out-of-Pocket Rx Prices
Has the era of lower out-of-pocket drug prices finally arrived?
Poll: Stigma & Misinformation May Stymie Gout Treatment
New survey data reveals that stigma, lack of awareness and misinformation may hinder treatment for gout, a chronic disease characterized by sudden and excruciating attacks. The national poll, conducted by Alliance for Gout Awareness, surveyed 169 gout patients across the country about their experiences with the disease and their beliefs about treatment.
The Hep C Cure Subscription
Monthly subscription for streaming music? Sure. Unlimited gym access? Of course. Favorite Netflix shows? Yep. But hepatitis C treatment by subscription?
Maybe so.
England Sets Sights on Heart Health
England has a plan. It’s comprehensive, long term and aimed at preventing 150,000 heart attacks and strokes over the next 10 years. How? By, among other measures, reducing high cholesterol, hypertension and atrial fibrillation.
My Co-Pay Accumulator Story
“Important Prescription Plan Change,” the letter announced. “We’re writing to inform you of an important upcoming change to your specialty prescription benefits.”
A “Favourite” Film Spotlights Gout
A darling of Hollywood’s movie awards season is inviting discussion on an unexpected topic: gout.
ICER vs. Infants
An incomplete and poorly conceived report from the controversial Institute for Clinical and Economic Review has set its sights on a most unbecoming target: infants with a degenerative, life-threatening neurological condition.
Watching, Waiting for Access in Puerto Rico
While some hepatitis C patients stateside are rejoicing at newly-relaxed barriers to curative treatment, those covered by Medicaid in Puerto Rico must watch and wait.
